Journal of the International Foot & Ankle Foundation 2022-10-01T00:00:00+00:00 Craig E. Clifford, DPM, MHA, FACFAS, FACPM Open Journal Systems <p>The Journal of the International Foot &amp; Ankle Foundation (JIFAF) is an open-access peer-reviewed international journal with a focus on foot and ankle medicine and surgery. It is the official publication of the <strong><a href="">International Foot &amp; Ankle Foundation</a></strong>. Established in 2022, the journal is the continuation of the <strong><a href="" target="_blank" rel="noopener">Foot and Ankle Online Journal (FAOJ)</a></strong>, which ran from 2008 through 2020. JIFAF is the ideal platform for practitioners, residents and students to publish case related material quickly and easily for distribution online absolutely free of charge. Its purpose is to provide a quality journal to further promote education and research in foot and ankle medicine and surgery.</p> Survey of knowledge about anatomy and management of plantar fasciitis 2022-07-15T08:02:15+00:00 Rahul Shetty Ian Reilly KP Iyengar Mark Gallagher Rajesh Botchu DRBRAJESH@YAHOO.COM <p><strong>Aim: </strong><span style="font-weight: 400;">To analyse the anatomical knowledge, understanding of pathology and clinical practice perception of Plantar Fasciitis amongst Clinicians, Podiatrists and Allied Health Professionals.</span></p> <p><strong>Materials and Methods: </strong><span style="font-weight: 400;">An online cross-sectional survey consisting of nine multiple choice questions was compiled and distributed amongst orthopaedic surgeons, radiologists, podiatrists, physiotherapists and other allied health professionals throughout the UK to ascertain the following: a) Anatomical knowledge, b) Practice setting, c) Clinical management strategies </span></p> <p><strong>Results: </strong><span style="font-weight: 400;">There were 76 responses from Orthopaedic surgeons (28.9%), Radiologists (34.2%), Podiatrists (17.1%), Physiotherapists (14.5%), and other Allied Health Professionals (5.3%) from different settings across the UK. 56.6% chose the central band as the most affected in Plantar Fasciitis, while 43.4% picked the medial band. In the practice setting, 46.1% answered that their site of injection is central, with 47.4% injecting the medial site. Corticosteroids are the most common treatment modality for injection with 64.5% answers, while 26.3% do not use injection as a treatment.</span></p> <p><strong>Conclusion:</strong><span style="font-weight: 400;">There is a wide variation between health professionals regarding the pathoanatomy of Plantar Fasciitis. Plantar heel pain (PHP) is a very common musculoskeletal problem with a high rate of prevalence in the community and contributes to long-term morbidity and poor quality of life. An approach involving the education and enhanced circulation of the characteristic pathoanatomic knowledge of PHP will lead to a better understanding and management of this common condition.</span></p> 2022-10-01T00:00:00+00:00 Copyright (c) 2022 Journal of the International Foot & Ankle Foundation Conversion of hindfoot intramedullary nail arthrodesis to total ankle arthroplasty: A case study 2022-07-31T22:30:51+00:00 Timothy Ford Nicholas Laco Michael Sweeney <p><span style="font-weight: 400;">Ankle arthrodesis has long been the gold standard for ankle arthritis but issues such as adjacent joint arthritis, non-union, and malunion are common complications. Total ankle arthroplasty (TAA) has gained popularity with recent encouraging long-term results and conversion of ankle arthrodesis to arthroplasty is now being offered. This case study reports a total ankle arthroplasty conversion from a retrograde hindfoot intramedullary nail in a 25 year old female with a history of trauma and several operations. This case describes a rare instance for this particular procedure due to the arthrodesis performed by an intramedullary hindfoot nail complicated by malunion.</span></p> 2022-10-01T00:00:00+00:00 Copyright (c) 2022 Journal of the International Foot & Ankle Foundation Pressure Offloading Injectable System (POIS): Evaluating the use of an injectable dermal filler for offloading painful pressure points during weight bearing activities 2022-08-23T01:03:43+00:00 Jodi Schoenhaus Jason Gold Aaron McFarlane <p><span style="font-weight: 400;">Fat pad atrophy is a condition characterized by the loss of natural fat on the plantar aspect of the foot. Fat pad restoration techniques directly address fat pad atrophy by increasing the overall thickness of subcutaneous tissue in the foot. Two subtypes of fat pad restoration, surgical dermal allograft and autolipotransplantation, are well-characterized treatment options for offloading high pressure regions of the foot. These methods have previously been shown to result in significant decreases in pain, improvement in the overall quality of life and decreases in the progression of dermal breakdown. However, the efficacy of a novel subtype of fat pad restoration, dermal injectables, is poorly characterized. This prospective, within-subjects design trial of thirty participants evaluated the safety and efficacy of an injectable hyaluronic acid dermal filler by measuring quality of life scores, ultrasound subcutaneous tissue thickness and gait pressure analysis. Each participant was followed for a one-year period with each study variable analyzed at 2 weeks, 12 weeks, 24 weeks and 54 weeks post-injection. Our study results revealed that a 1 milliliter injection of Juvederm® Voluma XC into regions of the foot with fat pad atrophy resulted in significantly higher Foot and Ankle Disability Index (FADI) scores over 54 weeks post-injection (p &lt; 0.001, versus baseline), and significantly higher subcutaneous layer thickness over 54 weeks post-injection (p &lt; 0.01, versus baseline), while no significant changes in the impulse gait percentages throughout the course of the study were evident (p &gt;&gt; 0.05, versus baseline). While follow-up studies are necessary, our preliminary study strongly suggests that Juvederm® Voluma XC (and other similar injectable dermal fillers) may present an efficacious, non-invasive, alternative treatment option to address fat pad atrophy.</span></p> 2022-10-01T00:00:00+00:00 Copyright (c) 2022 Journal of the International Foot & Ankle Foundation